ALERT

Due to the Software User Group Conference, there may be a slight delay on general support requests. For urgent matters, please add "Urgent" to the ticket subject and we will prioritize those requests first.

Leukemia/Lymphoma Xenograft Core (LLX)

To expedite the translation of biologic discoveries into novel therapeutics, there is a pressing need for panels of in vivo models that capture the molecular complexity of human disease. While traditional cell lines and genetically engineered mouse models are useful tools, they are insufficient to assess the broad diversity of human tumors within a context that recapitulates in situ biology. Patient-derived xenografts (PDXs), generated by transplanting primary human tumor cells into immune-deficient NSG mice, surmount some of the limitations of these traditional platforms and have been increasingly utilized as tools for preclinical investigation. However, the infrastructure required to generate, bank, and characterize PDX models limits their availability to only a few investigators. To address this issue, we established a repository of PDX models of leukemia and lymphoma, which we have named the Public Repository of Xenografts (PRoXe). The repository encompasses AML, B- and T-ALL, and B- and T-cell non-Hodgkin lymphoma across a range of cytogenetic- and molecularly-defined subtypes. PRoXe is extensively annotated with patient-level information, including demographics, phase of treatment, prior therapies, tumor immunophenotye, cytogenetics, and molecular diagnostics. PDX lines available for distribution are characterized by immunophenotyping, whole transcriptome sequencing (RNAseq), and targeted exon sequencing of ~300 genes. 

 

The Leukemia/Lymphoma Xenograft Core was established to expand our xenografting efforts and to expedite sample allocation to interested investigators.

Leadership

Amanda Christie - Director
Room: Dana 512
Phone: 617-582-8868
Email: amandal_christie@dfci.harvard.edu

David Weinstock - Faculty Sponsor
Room: Dana 510B
Phone: 617-632-5810
Email: davidm_weinstock@dfci.harvard.edu 

Information for external users

Purchase Orders are to be made out to:

Dana-Farber Cancer Institute

General Accounting, BP-430

450 Brookline Avenue

Boston, MA 02215-5450

Location and hours of operation

Hours Location

Monday - Friday 8:00am - 4:30pm  

44 Binney Street

Boston, MA 02215

Links and Resources

  1. Public Repository of Xenografts (PRoXe)